Acadia Healthcare Target of Unusually High Options Trading (ACHC)

Share on StockTwits

Acadia Healthcare Company Inc (NASDAQ:ACHC) was the recipient of unusually large options trading on Tuesday. Stock investors purchased 5,378 put options on the stock. This represents an increase of 1,023% compared to the typical volume of 479 put options.

Shares of NASDAQ ACHC opened at $39.00 on Wednesday. Acadia Healthcare has a 52-week low of $26.92 and a 52-week high of $45.35. The firm has a market cap of $3.95 billion, a PE ratio of 16.96, a P/E/G ratio of 1.60 and a beta of 0.22. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Monday, November 5th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.64 by ($0.09). Acadia Healthcare had a net margin of 7.52% and a return on equity of 7.93%. The company had revenue of $760.90 million for the quarter, compared to analysts’ expectations of $760.46 million. During the same period in the prior year, the firm earned $0.58 earnings per share. The firm’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts expect that Acadia Healthcare will post 2.52 EPS for the current fiscal year.

Several research analysts have weighed in on the company. Jefferies Financial Group boosted their price target on Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a report on Tuesday, July 31st. ValuEngine upgraded Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, July 26th. BMO Capital Markets downgraded Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 price target for the company. in a report on Wednesday, August 1st. BidaskClub upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, September 6th. Finally, Credit Suisse Group boosted their price target on Acadia Healthcare from $40.00 to $44.00 and gave the company a “neutral” rating in a report on Tuesday, July 31st. Eight equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $43.11.

In other Acadia Healthcare news, Director Reeve B. Waud sold 41,865 shares of the business’s stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the transaction, the director now directly owns 14,213 shares in the company, valued at approximately $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.50% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. GW&K Investment Management LLC grew its stake in shares of Acadia Healthcare by 0.5% during the 3rd quarter. GW&K Investment Management LLC now owns 483,135 shares of the company’s stock valued at $17,006,000 after buying an additional 2,427 shares during the period. LSV Asset Management purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $6,279,000. Systematic Financial Management LP purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $1,266,000. Bbva Compass Bancshares Inc. boosted its position in Acadia Healthcare by 29.7% during the 3rd quarter. Bbva Compass Bancshares Inc. now owns 8,222 shares of the company’s stock worth $289,000 after purchasing an additional 1,884 shares during the period. Finally, Condor Capital Management boosted its position in Acadia Healthcare by 9.0% during the 3rd quarter. Condor Capital Management now owns 19,526 shares of the company’s stock worth $687,000 after purchasing an additional 1,611 shares during the period.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Week Herald and is the property of of Week Herald. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://weekherald.com/2018/11/07/acadia-healthcare-target-of-unusually-high-options-trading-achc.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Penny Stocks

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply